Skip to main content
. 2008 Sep 4;150(1):385–395. doi: 10.1210/en.2008-0674

Table 4.

Effects of treatment on body weight, BMD, and androgen-dependent organ weights

Group EB (μg/d) S-23 (mg/d) Animal numbers Body weight (g) BMD (g/cm2) Prostate (percent of intact control) Seminal vesicles (percent of intact control) Levator ani muscle (percent of intact control) Testis (percent of intact control)
1 6 423 ± 29 0.172 ± 0.0057 100 ± 20 100 ± 7.5 100 ± 15 100 ± 10
2 5 5 351 ± 8.0I 0.181 ± 0.0036I 46.9 ± 15I 28.1 ± 12I 62 ± 5.6I 94 ± 10
3 5 0.05 6 379 ± 20I 0.188 ± 0.0036I,E 34.4 ± 7.6I 23.9 ± 7.6I 90 ± 11E 69 ± 14I,E
4 5 0.1 6 376 ± 26I 0.183 ± 0.0040I 31.1 ± 6.6I 21.8 ± 5.3I 97 ± 15E 34 ± 3.8I,E
5 5 0.3 6 387 ± 25I,E 0.188 ± 0.0085I 45.1 ± 5.3I 52 ± 8.7I,E 100 ± 3.8E 45 ± 3.9I,E
6 5 0.5 6 351 ± 9.0I 0.184 ± 0.0037I 78.2 ± 5.6I,E 89 ± 4.8E 123 ± 8.5I,E 63 ± 6.3I,E
7 5 0.75 6 344 ± 11I 0.183 ± 0.0036I 94.7 ± 89.2E 113 ± 12I,E 131 ± 8.1I,E 75 ± 7.2I,E

Rats were treated for 70 d via sc injection. Data presented as mean ± sd. I and E, Significant difference between the group and intact control group or EB control group, respectively, as analyzed by single-factor ANOVA with P < 0.05.